PharmaShots Weekly Snapshots (Feb 15- 19, 2021)

RedHill Signs a Manufacturing Agreement with Cosmo for Movantik and RHB-204

Published: Feb 19, 2021 | Tags: RedHill, Signs, Manufacturing, Agreement, Cosmo, Movantik, RHB-204

Astellas and Seagen Reports Submission of Two BLA to the US FDA for Padcev (enfortumab vedotin) in Locally Advanced or Metastatic Urothelial Cancer

Published: Feb 19, 2021 | Tags: Astellas, Seagen, Reports, Submission, Two, BLA, US, FDA, Padcev (enfortumab vedotin), Locally, Advanced, Metastatic, Urothelial Cancer

The US FDA Approves Patient Specific Talus Spacer to Treat AVN of Ankle Joint as a Humanitarian Use Device

Published: Feb 19, 2021 | Tags: US, FDA, Approves, Patient, Specific, Talus Spacer, Treat, AVN, Ankle Joint, Humanitarian, Use, Device

Dermavant Report Results of Tapinarof Cream in P-III PSOARING 3 Study with Durable and Remittive Benefits for Plaque Psoriasis

Published: Feb 19, 2021 | Tags: Dermavant, Report, Results, Tapinarof Cream, P-III, PSOARING 3, Study, Durable, Remittive Benefits, Plaque Psoriasis

Fresenius Kabi Launches Idacio (biosimilar, adalimumab) for Multiple Chronic Inflammatory Conditions in Canada

Published: Feb 19, 2021 | Tags: Fresenius Kabi, Launches, Idacio (biosimilar, adalimumab), Multiple Chronic Inflammatory, Conditions, Canada

Lilly Collaborates with Rigel to Develop RIPK1 Inhibitors for Immunological and Neurodegenerative Diseases

Published: Feb 19, 2021 | Tags: Lilly, Collaborates, Rigel, Develop, RIPK1 Inhibitors, Immunological ,Neurodegenerative Diseases

BeiGene Reports the US FDA’s Acceptance of sNDA for Brukinsa (zanubrutinib) in Waldenström’s Macroglobulinemia

Published: Feb 18, 2021 | Tags: BeiGene, Reports, US, FDA, Acceptance, sNDA, Brukinsa (zanubrutinib), Waldenström’s Macroglobulinemia

Myovant and Pfizer Publish the Results of Relugolix Combination Regimen in P-III LIBERTY Studies in NEJM

Published: Feb 18, 2021 | Tags: Myovant, Pfizer, Publish, Results, Relugolix, Combination, Regimen ,P-III, LIBERTY, Studies, NEJM

GSK Expand its 2020 Collaboration with Vir to Advance New Therapies for Influenza and Other Respiratory Viruses

Published: Feb 18, 2021 | Tags: GSK, Expand, 2020, Collaboration, Vir, Advance, New, Therapies, Influenza, Other, Respiratory, Viruses

Novartis Collaborates with Bill & Melinda Gates Foundation to Discover and Develop Gene Therapy for Sickle Cell Disease

Published: Feb 18, 2021 | Tags: Novartis, Collaborates, Bill & Melinda, Gates Foundation, Discover ,Develop, Gene Therapy, Sickle Cell Disease

Lilly Reports Results of Tirzepatide in P-lll SURPASS-3 and 5 Trials for Type-2 Diabetes

Published: Feb 18, 2021 | Tags: Lilly, Reports, Results, Tirzepatide, P-lll, SURPASS-3 and 5, Trials, Type-2 Diabetes

Coherus Reports the US FDA’s Acceptance of BLA for CHS-1420 (biosimilar, adalimumab)

Published: Feb 18, 2021 | Tags: Coherus, Reports, US, FDA, Acceptance, BLA, CHS-1420 (biosimilar, adalimumab)

Boehringer Ingelheim Animal Health Establishes Pawru for its PetPro Portfolio

Published: Feb 17, 2021 | Tags: Boehringer Ingelheim, Animal Health, Establishes, Pawru, PetPro Portfolio

Novartis’s Entresto Receives US FDA’s Approval for Chronic Heart Failure

Published: Feb 17, 2021 | Tags: Novartis, Entresto, Receives, US, FDA, Approval, Chronic Heart Failure

GSK Initiates P-III study for RSV Candidate Vaccine Programme for Older Adults

Published: Feb 17, 2021 | Tags: GSK, Initiates, P-III study, RSV, Candidate, Vaccine, Programme, Older, Adults

Novartis Report Results of Kesimpta (ofatumumab) Sensoready Autoinjector Pen for Multiple Sclerosis

Published: Feb 17, 2021 | Tags: Novartis, Report, Results, Kesimpta (ofatumumab), Sensoready, Autoinjector Pen, Multiple Sclerosis

BMS and Acceleron’s Reblozyl (Luspatercept) Receives Health Canada Approval for Adult Patients With Myelodysplastic Syndromes

Published: Feb 17, 2021 | Tags: BMS and Acceleron, Reblozyl (Luspatercept), Receives, Health Canada, Approval, Adult Patients, Myelodysplastic Syndromes

Guardant Health Launches Guardant Reveal Liquid Biopsy Test for Early-Stage Colorectal Cancer

Published: Feb 17, 2021 | Tags: Guardant Health, Launches, Guardant Reveal, Liquid, Biopsy Test, Early Stage, Colorectal Cancer

Onward Signs a Worldwide Exclusive License and Co-Development Agreement with Biomunex for Immuno-Oncology

Published: Feb 16, 2021 | Tags: Onward, Signs, Worldwide, Exclusive, License, Co-Development ,Agreement, Biomunex, Immuno-Oncology

Aker BioMarine Collaborate with Université de Sherbrooke Department of Medicine for Alzheimer’s Disease

Published: Feb 16, 2021 | Tags: Aker BioMarine, Collaborate, Université de Sherbrooke, Department, Medicine, Alzheimer’s Disease

AstraZeneca and Serum Institute of India’s COVID-19 Vaccine Receive WHO’s EUA to Prevent COVID-19

Published: Feb 16, 2021 | Tags: AstraZeneca and Serum Institute of India, COVID-19 Vaccine, Receive ,WHO, EUA, Prevent, COVID-19

Targovax Receives US FDA’s Fast Track Designation for ONCOS-102 for Malignant Pleural Mesothelioma

Published: Feb 16, 2021 | Tags: Targovax, Receives, US, FDA, Fast Track Designation, ONCOS-102, Malignant Pleural Mesothelioma

Celltrion Receives EC’s Approval for Yuflyma (biosimilar, adalimumab) for the Treatment of Multiple Chronic Inflammatory Diseases

Published: Feb 16, 2021 | Tags: Celltrion, Receives, EC, Approval, Yuflyma (biosimilar, adalimumab), Treatment, Multiple Chronic Inflammatory,, Diseases

Exelixis Report Results of Cabometyx (cabozantinib) in P-II PAPMET Study for Patients with Metastatic Papillary Renal Cell Carcinoma

Published: Feb 16, 2021 | Tags: Exelixis, Report, Results, Cabometyx (cabozantinib), P-II, PAPMET Study, Patients, Metastatic, Papillary, Renal Cell Carcinoma

Roche’s Receives the US FDA’s Clearance for Urine Sample Type for BK Virus Quantitative Test

Published: Feb 15, 2021 | Tags: Roche, Receives, US, FDA, Clearance, Urine Sample, Type, BK Virus, Quantitative Test

Biocon Biologics and Viatris Receive EC’s Approval for Kixelle (biosimilar, insulin aspart) for Diabetes Mellitus

Published: Feb 15, 2021 | Tags: Biocon Biologics and Viatris, Receive, EC, Approval, Kixelle (biosimilar, insulin aspart), Diabetes Mellitus

Merck Report Result of Keytruda (pembrolizumab) + Lenvima (lenvatinib) as 1L Treatment for Advanced Renal Cell Carcinoma

Published: Feb 15, 2021 | Tags: Merck, Report, Result, Keytruda (pembrolizumab) + Lenvima (lenvatinib), 1L, Treatment, Advanced Renal Cell Carcinoma

Pfizer’s Panzyga Receives the US FDA’s Approval of sBLA for Chronic Inflammatory Demyelinating Polyneuropathy

Published: Feb 15, 2021 | Tags: Pfizer, Panzyga, Receives, US, FDA, Approval, sBLA, Chronic Inflammatory, Demyelinating, Polyneuropathy

Takeda Report Results of TAK-620 (maribavir) in P-III SOLCTICE Trial for the Treatment of Post-Transplant Patients with Cytomegalovirus Infection

Published: Feb 15, 2021 | Tags: Takeda, Report, Results, TAK-620 (maribavir), P-III, SOLCTICE Trial, Treatment, Post Transplant, Patients, Cytomegalovirus Infection

G1 Therapeutics’ Cosela (trilaciclib) Receives US FDA’s Approval as the First Myeloprotection Therapy for Extensive-Stage Small Cell Lung Cancer

Published: Feb 15, 2021 | Tags: G1 Therapeutics, Cosela (trilaciclib), Receives, US, FDA, Approval, First, Myeloprotection, Therapy, Extensive Stage, Small Cell, Lung Cancer

The post PharmaShots Weekly Snapshots (Feb 15- 19, 2021) first appeared on PharmaShots.